_version_ |
1827333205541257216
|
collection |
DOAJ
|
first_indexed |
2024-03-07T17:16:50Z
|
format |
Article
|
id |
doaj.art-26923e7bde6741a2a117a82215a701f8
|
institution |
Directory Open Access Journal
|
issn |
2572-9241
|
language |
English
|
last_indexed |
2024-03-07T17:16:50Z
|
publishDate |
2022-06-01
|
publisher |
Wiley
|
record_format |
Article
|
series |
HemaSphere
|
spelling |
doaj.art-26923e7bde6741a2a117a82215a701f82024-03-02T21:59:16ZengWileyHemaSphere2572-92412022-06-0166e73110.1097/HS9.0000000000000731202206000-00007Correction Notice: Serologic Responses to COVID-19 Vaccines in Hematological Patients Are Predominantly Impaired in Lymphoid but not in Myeloid Malignancieshttp://journals.lww.com/10.1097/HS9.0000000000000731
|
spellingShingle |
Correction Notice: Serologic Responses to COVID-19 Vaccines in Hematological Patients Are Predominantly Impaired in Lymphoid but not in Myeloid Malignancies
HemaSphere
|
title |
Correction Notice: Serologic Responses to COVID-19 Vaccines in Hematological Patients Are Predominantly Impaired in Lymphoid but not in Myeloid Malignancies
|
title_full |
Correction Notice: Serologic Responses to COVID-19 Vaccines in Hematological Patients Are Predominantly Impaired in Lymphoid but not in Myeloid Malignancies
|
title_fullStr |
Correction Notice: Serologic Responses to COVID-19 Vaccines in Hematological Patients Are Predominantly Impaired in Lymphoid but not in Myeloid Malignancies
|
title_full_unstemmed |
Correction Notice: Serologic Responses to COVID-19 Vaccines in Hematological Patients Are Predominantly Impaired in Lymphoid but not in Myeloid Malignancies
|
title_short |
Correction Notice: Serologic Responses to COVID-19 Vaccines in Hematological Patients Are Predominantly Impaired in Lymphoid but not in Myeloid Malignancies
|
title_sort |
correction notice serologic responses to covid 19 vaccines in hematological patients are predominantly impaired in lymphoid but not in myeloid malignancies
|
url |
http://journals.lww.com/10.1097/HS9.0000000000000731
|